Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-251395

Chief Scientific Officer sold 6,000 shares at $19.87 ($119,220)

  • Chief Scientific Officer acquired 6,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Townson Sharon · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-29 Exercise or conversion : show line 1 in the form 10b5-1 +6,000 $6.14 $36,840 73,845 D
2026-05-29 Sale : show line 2 in the form 10b5-1 −6,000 $19.87 $119,220 67,845 D
Open-market sales · 6,000 sh · avg $19.87 · $119,220

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-29 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −6,000 209,290 D
Loading xslF345X06/ownership.xml…